A study in people with obesity or overweight.

Recruiting now. Registry record last updated July 31, 2026.

Who can join: Adults 18+, have obesity or are overweight, BMI 27.5+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The full study runs about 2 years.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor Texas Tech UniversityDrug tirzepatideClass GLP-1/GIPSites 1 USEnrollment target 27

What this study is for

Primary condition: Obesity & Overweight. Also studied in: Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health.

Full scientific study title: Tirzepatide Impact Assessment Study.

Who can join

Age18 and upSexAnyBMI27.5 or higher

Adults 18+, have obesity or are overweight, BMI 27.5+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

Age 18 years or older
BMI of 27.5 kg/m2 or higher
For GLP-1 RA arm: initiating semaglutide or tirzepatide for weight loss as prescribed by their own medical provider
For LS comparator arm: not currently taking a GLP-1 receptor agonist or other weight-loss medication, and no use of weight-loss medication within the past 3 months

Key exclusion criteria

Pregnant
Breastfeeding
Wears a pacemaker or other internal medical device
Chronic kidney disease in the past 2 years
Active cancer or cancer treatment within the past 6 months

Where this trial is enrolling

This trial has 1 sites across 1 state. Contact a site coordinator directly to start screening.

Texas1 site

Nutrition Metabolic Health Initiative (NMHI)
Lubbock, Texas
Shannon Dr. Galyean, PhD+18068342286Shannon.Galyean@ttu.edu

Follow this trial

We email you if NCT07740291 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Started enrolling: January 2, 2025. Expected completion: December 7, 2026. Last updated on ClinicalTrials.gov: July 31, 2026.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.